AB-FUBICA (Compound 13) is a CB1 and CB2 receptor agonist that activates G protein-coupled inwardly-rectifying potassium channels (GIRK) through binding to CB1 and CB2 receptors, demonstrating significant cannabinoid-like activity. Its EC50 values are 21 nM for CB1 and 15 nM for CB2. AB-FUBICA may be applicable for research in pain management, neurodegenerative diseases, and inflammation-related mechanisms.
Molekulargewicht:
367.42
CAS Nummer:
[1801338-22-6]
Formel:
C21H22FN3O2
Target-Kategorie:
Cannabinoid Receptor|||Potassium Channel
T203550
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
